Analyst Ratings for Akebia Therapeutics (AKBA)
AKBA Rating Summary
AKBA Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $1.00 (Leerink)
- Average: $3.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.88 (+307.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
Avg. $ Target:
$3.88 (+307.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2026 | WestPark Capital | N/A | New Coverage | Buy (N/A) |
4.50 (N/A) |
0.97 (0.95) |
-2.06% | Details |
| 8/7/2026 | Leerink | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.95 (0.95) |
0% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
